Pancreatic Cancer Research

ResearcherTaizhou Municipal HospitalNo recent work listed

Peiyuan Cai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-8425-4087; OpenAlex author ID A5010196417. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. Diagnostic value of combining preoperative inflammatory markers ratios with CA199 for patients with early-stage pancreatic cancer. Co-author DOI 10.1186/s12885-023-10653-4↗
  2. Inhibition of glutathione metabolism can limit the development of pancreatic cancer. Co-author DOI 10.4252/wjsc.v14.i5.362↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuanlong Gu · 1 shared paper, 2023 · strength 0.18
  2. Changjie Lou · 1 shared paper, 2023 · strength 0.18
  3. Juan Zhao · 1 shared paper, 2023 · strength 0.18
  4. Wei Wang · 1 shared paper, 2022 · strength 0.17
  5. Yan Wang · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.